文献速递肝胆胰外科围术期管理与 ERAS

慢性肾病KDIGO分级与肝切除术后短期结局的关系

Kidney Disease: Improving Global Outcomes Classification of Chronic Kidney Disease and Short-Term Outcomes of Patients Undergoing Liver Resection.
PubMed 文献 · J Am Coll Surg · 2022-01-01

本研究基于ACS NSQIP 2014-2018年肝切除患者18,321例,按KDIGO分级评估术前肾功能与术后30天死亡率的关系。结果显示CKD程度越重,术后并发症、延长住院及30天死亡风险越高,且KDIGO分级可在NSQIP风险计算器内进一步分层患者。

要点

  • CKD程度越重,肝切除术后并发症和30天死亡风险越高
  • KDIGO分级可在NSQIP风险计算器基础上进一步分层患者
  • 原发性肝癌行大范围肝切除者,CKD G2-5的30天死亡率是正常肾功能者的2倍

核心结论

  • CKD程度与肝切除术后并发症及30天死亡风险相关,术前风险估计应重视CKD分级。

研究设计与样本

  • 回顾性队列研究,纳入ACS NSQIP 2014-2018年间接受肝切除的患者18,321例,按KDIGO分级分为G1、G2-3、G4-5三组。

主要发现

  • 年龄>70岁和ASA 3级患者重度CKD发生率更高(均p<0.001)。
  • G2-3和G4-5 CKD患者更易出现延长住院和术后并发症(均p<0.001)。
  • 校正后30天死亡比值比随CKD加重而升高(p=0.03)。
  • KDIGO分级可在NSQIP风险计算器内对患者进行分层。
  • 原发性肝癌行大范围肝切除者,G2-3和G4-5 CKD的30天死亡率是正常肾功能者的2倍(p=0.03)。

关键数值与推荐

  • G1:正常/高功能,eGFR≥90 ml/min/1.73m2;G2-3:轻/中度CKD,eGFR 89-30 ml/min/1.73m2;G4-5:重度CKD,eGFR≤29 ml/min/1.73m2。

临床怎么用

  • 肝切除术前应常规评估肾功能并按KDIGO分级分层,用于术后风险预测和患者沟通。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The impact of chronic kidney disease (CKD) on surgery is still not well defined. We sought to characterize the association of preoperative CKD with 30-day mortality after hepatic resection. METHODS: Patients included in the American College of Surgeons (ACS) NSQIP who underwent hepatectomy between 2014 and 2018 were identified. Kidney function was stratified according to the "Kidney Disease: Improving Global Outcomes" (KDIGO) Classification: G1, normal/high function (estimated glomerular-filtration-rate ≥ 90 ml/min/1.73m2); G2-3, mild/moderate CKD (89-30 ml/min/1.73m2); G4-5, severe CKD (≤ 29 ml/min/1.73m2). RESULTS: Overall, 18,321 patients were included. Older patients (ie more than 70 years old) and those with serious medical comorbidities (ie American Society of Anesthesiologists [ASA] class 3) had an increased incidence of severe CKD (both p < 0.001). Patients with G2-3 and G4-5 CKD were more likely to have a prolonged length of stay and to experience postoperative complications (both p < 0.001). Adjusted odds of 30-day mortality increased with the worsening CKD (p = 0.03). The degree of CKD was able to stratify patients within the NSQIP risk calculator. Among patients who underwent major hepatectomy for primary cancer, the rate of 30-day mortality was 2-fold higher with G2-3 and G4-5 CKD vs normal kidney function (p = 0.03). CONCLUSIONS: The degree of CKD was related to the risk of complications and 30-day mortality after hepatectomy. CKD classification should be strongly considered in the preoperative risk estimation of these patients.

来源:J Am Coll Surg,查看原文。版权归原作者所有。

引用

  1. Bagante F, Alaimo L, Tsilimigras D, et al. Kidney Disease: Improving Global Outcomes Classification of Chronic Kidney Disease and Short-Term Outcomes of Patients Undergoing Liver Resection. J Am Coll Surg. 2022. PMID: 35426395. doi:10.1097/XCS.0000000000000112

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。